Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter
DOI 10.1056/NEJMoa054686
Singh BN, Connolly SJ, Crijns HJ, et al. Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl J Med 2007;357:987-99. (Pubitemid 47367078)
Effect of dronedarone on cardiovascular events in atrial fibrillation
Errata, N Engl J Med 2009;360:2487, 2011;364:1481
Hohnloser SH, Crijns H, van Eickels M, et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009;360:668-78. [Errata, N Engl J Med 2009;360:2487, 2011;364:1481.]
Analysis of stroke in ATHENA: A placebo-controlled, double-blind, parallelarm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter
Connolly SJ, Crijns HJ, Torp-Pedersen C, et al. Analysis of stroke in ATHENA: a placebo-controlled, double-blind, parallelarm trial to assess the efficacy of dronedarone 400 mg BID for the prevention of cardiovascular hospitalization or death from any cause in patients with atrial fibrillation/atrial flutter. Circulation 2009;120:1174-80.
Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: Follow-up of the Euro Heart Survey on Atrial Fibrillation
DOI 10.1093/eurheartj/ehn139
Nieuwlaat R, Prins MH, Le Heuzey JY, et al. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: follow-up of the Euro Heart Survey on atrial fibrillation. Eur Heart J 2008;29:1181-9. (Pubitemid 351844895)
Effect of dronedarone in patients with permanent atrial fibrillation during the ATHENA study
abstract
Nieuwlaat R, Hohnloser SH, Connolly SJ. Effect of dronedarone in patients with permanent atrial fibrillation during the ATHENA study. Eur Heart J 2011;32:Suppl:618. abstract.
Dronedarone for the control of ventricular rate in permanent atrial fibrillation: The Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study
Davy JM, Herold M, Hoglund C, et al. Dronedarone for the control of ventricular rate in permanent atrial fibrillation: the Efficacy and safety of dRonedArone for the cOntrol of ventricular rate during atrial fibrillation (ERATO) study. Am Heart J 2008;156(3):527.e1-527.e9.
Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the β2-adrenoceptor and adenylate cyclase in the rat heart
Chatelain P, Meysmans L, Matéazzi JR, Beaufort P, Cliniet M. Interaction of the antiarrhythmic agents SR 33589 and amiodarone with the β2-adrenoceptor and adenylate cyclase in the rat heart. Br J Pharmacol 1995;116:1949-56.
33589, a new amiodarone-like antiarrhythmic agent: Anti-adrenoceptor activity in anaesthetized and conscious dogs
Hodeige D, Heyndrickz JP, Chatelain P, Manning A. SR 33589, a new amiodarone-like antiarrhythmic agent: anti-adrenoceptor activity in anaesthetized and conscious dogs. Eur J Pharmacol 1995;279:25-32.
Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs
Finance O, Manning A, Chatelain P. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. J Cardiovasc Pharmacol 1995;26:570-6.
33589, a new amiodarone-like agent: Effect on ischemia- And reperfusion-induced arrhythmias in anesthetized rats
Manning AS, Bruynickx C, Ramboux J, Chatelain P. SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats. J Cardiovasc Pharmacol 1995;26:453-61.
Hemodynamic and antiadrenergic effects of dronedarone and amiodarone in animals with a healed myocardial infarction
Djandjighian L, Planchenault J, Finance O, Gautier P, Nisato D. Hemodynamic and antiadrenergic effects of dronedarone and amiodarone in animals with healed myocardial infarction. J Cardiovasc Pharmacol 2000;36:376-83. (Pubitemid 30660469)
Effect of dronedarone on exercise capacity and cardiac function in patients with severe left ventricular dysfunction and compensated stable heart failure
Levine TB, Giles T, Radzik E, Ghali JK. Effect of dronedarone on exercise capacity and cardiac function in patients with severe left ventricular dysfunction and compensated stable heart failure. Cardiovasc Drugs Ther 2010;24:449-58.
Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: Comparison with amiodarone
Varró A, Takacs J, Németh M, et al. Electrophysiological effects of dronedarone (SR 33589), a noniodinated amiodarone derivative in the canine heart: comparison with amiodarone. Br J Pharmacol 2001;133:625-34. (Pubitemid 32642867)
+ current, HERG and KvLQT1/minK potassium channels
DOI 10.1038/sj.bjp.0705502
Thomas D, Kathofer S, Zhang W, et al. Acute effects of dronedarone on both components of the cardiac delayed rectifier K+ current, HERG and KvLQT1/minK potassium channels. Br J Pharmacol 2003;140:996-1002. (Pubitemid 37464084)
Increased mortality after dronedarone therapy for severe heart failure
DOI 10.1056/NEJMoa0800456
Køber L, Torp-Pedersen C, McMurray JJV, et al. Increased mortality after dronedarone therapy for severe heart failure. N Engl J Med 2008;358:2678-87. [Erratum, N Engl J Med 2010;363:1384.] (Pubitemid 351860860)
Dronedarone in patients with congestive heart failure: Insights from ATHENA
Hohnloser SH, Crijns H, van Eickels M, et al. Dronedarone in patients with congestive heart failure: insights from ATHENA. Eur Heart J 2010;31:1717-21.
Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321:406-12.
Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction
DOI 10.1016/S0140-6736(96)02149-6
Waldo AL, Camm AJ, DeRuyter H, et al. Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. Lancet 1996;348:7-12. [Erratum, Lancet 1996;348:416.] (Pubitemid 26237238)
Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments. Final report of a multicenter study
Antman EM, Wenger TL, Butler VP Jr, Haber E, Smith TW. Treatment of 150 cases of life-threatening digitalis intoxication with digoxin-specific Fab antibody fragments: final report of a multicenter study. Circulation 1990;81:1744-52. (Pubitemid 20183822)
Association of Serum Digoxin Concentration and Outcomes in Patients with Heart Failure
DOI 10.1001/jama.289.7.871
Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003;289:871-8. (Pubitemid 37430346)
Rhythm- And rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial)
Page RL, Connolly SJ, Crijns HJ, et al. Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial). Am J Cardiol 2011;107:1019-22.